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Introduction
Hemorrhagic shock (HS) often cause coagulopathy and
cardiovascular dysfunction. The extent of these altera-
tions correlates with the severity of HS. Fresh Frozen
Plasma use is usually designed to restore coagulation
proteins levels. Clinical and experimental studies have
shown that resuscitation with fresh plasma is associated
with improved outcome after severe hemorrhagic shock.
Objectives
The benefical effect of FFP on coagulopathy is well docu-
mented but its effect on vascular dysfunction is not clear.
We hypothesized that in addition to its effects on hemos-
tasis, FFP has other protective effect on cardiovascular
dysfunction.
Methods
A Wistar rat model of Hemorrhagic shock (HS) was
used. Rats were anesthetized and instrumented for con-
tinuous monitoring of blood pressure, heart rate and
body temperature.
Rats with cannulated jugular and femoral veins were
subjected to withdrawals of 20mL/kg body weight of
blood for 15min; resuscitation fluids (vol/vol blood loss)
were infused over 45 minutes after HS. Different treat-
ments were studied : RBC+plasma of rats or RBC+HEA.
Four groups were studied : control (without HS), HS
(without treatment), HS+RBC+rat plasma and HS+RBC
+HEA. We evaluated survival to 300 min and hemody-
namic parameters. eNOS, P-eNOS, Bax and Bcl2 levels in
the aorta tissue were determined by Western Blot.
Results
Plasma and HEA treatment improved significantly survi-
val up to 300min and restored hemodynamics para-
meters (arterial pressure, heart rate, carotid blood flow).
These results are in agreement with P-eNOS/eNOS
ratio. The protein level showed that HS increased apop-
tosis in aorta as determined by Bax/Bcl2 ratio expres-
sion (p < 0.05). Plasma infusion resulted in significantly
less apoptosis than HEA resuscitation. These results
suggest that plasma may have a protective effect on vas-
cular function.
Conclusions
Plasma and HEA resuscitation have the same beneficial
effects on survival and haemodynamic parameters. How-
ever, plasma seems to have additional benefical effect on
apoptosis as compared to HEA, but the clinical signifi-
cance remains to be determined.
HS: Hemorrhagic Shock, Voluven®: HEA, RBC: Red
Blood Cells
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